Director of Drug Discovery at MRC Technology and Honorary Professor, Queen Mary University of London

Justin Bryans is Director of Drug Discovery at the Medical Research Council Technology’s (MRCT) Centre for Therapeutics Discovery, working on small molecule and antibody projects. He joined MRCT in 2005.

He has worked for over 20 years as a medicinal chemist in a number of biotechnology and pharmaceutical companies, including Xenova, Parke-Davis and Pfizer.

Justin is also an Honorary Professor at Queen Mary University of London (QMUL) and undertakes teaching on drug discovery at QMUL, University College London and the Wellcome Trust.

Experience

  • –present
    Director of Drug Discovery at MRC Technology and Honorary Professor, Queen Mary University of London